KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Prepaid Assets (2018 - 2025)

Adaptive Biotechnologies' Prepaid Assets history spans 8 years, with the latest figure at $13.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 15.35% year-over-year to $13.0 million; the TTM value through Dec 2025 reached $13.0 million, up 15.35%, while the annual FY2025 figure was $13.0 million, 15.35% up from the prior year.
  • Prepaid Assets for Q4 2025 was $13.0 million at Adaptive Biotechnologies, down from $13.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $16.6 million in Q3 2021 and bottomed at $9.1 million in Q2 2023.
  • The 5-year median for Prepaid Assets is $12.1 million (2022), against an average of $11.9 million.
  • The largest annual shift saw Prepaid Assets surged 41.23% in 2021 before it decreased 27.47% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $13.0 million in 2021, then fell by 27.47% to $9.4 million in 2022, then rose by 20.44% to $11.4 million in 2023, then dropped by 0.73% to $11.3 million in 2024, then rose by 15.35% to $13.0 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Prepaid Assets are $13.0 million (Q4 2025), $13.9 million (Q3 2025), and $11.3 million (Q2 2025).